Eli Lilly LLY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $25.28B+22.5% | $20.64B+12.1% | $18.41B+33.4% | $13.8B+24.3% | $11.11B+4.9% | ||
| $2.04B+2.3% | $2B+5.3% | $1.9B+0.2% | $1.89B+3.5% | $1.83B+3.5% | ||
| $633M+1.1% | $626M-1.0% | $632.2M+2.9% | $614.3M-4.1% | $640.6M-0.8% | ||
| —— | —— | —— | $2.86B+2.2% | $2.8B+4.2% | ||
| —— | $4.67B+13.1% | $4.13B+15.1% | $3.59B+17.7% | $3.05B+21.6% | ||
| —— | $10.19B+22.8% | $8.29B+29.6% | $6.4B+42.1% | $4.5B+72.6% | ||
| —— | $6.61B+14.2% | $5.79B+16.5% | $4.97B+19.7% | $4.15B+24.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | $7B+20.9% | $5.79B+26.5% | $4.58B+36.0% | $3.37B+56.2% | ||
| $20.48B+21.8% | $16.81B+4.7% | $16.06B+46.8% | $10.94B+17.4% | $9.32B+5.7% | ||
| $8.66B+10.4% | $7.84B+15.5% | $6.79B+12.2% | $6.05B+8.5% | $5.58B+10.4% | ||
| $1.72B+160% | $661M+20.2% | $549.7M— | —— | —— | ||
| $745M+15.5% | $645M-3.7% | $669.9M-15.7% | $794.8M+5.0% | $756.9M+11.8% | ||
| $141M+14,200% | -$1M-100% | $734M+123% | $329.8M+271% | $88.8M-64.2% | ||
| —— | —— | —— | —— | —— | ||
| -$11.54B-5.1% | -$10.97B-8.7% | -$10.09B+9.2% | -$11.11B+3.2% | -$11.48B-23.4% | ||
| $5.59B+3.8% | $5.38B+3.4% | $5.21B+3.5% | $5.03B+3.6% | $4.86B+3.8% | ||
| $5.26B+28.1% | $4.11B-11.7% | $4.65B+6.0% | $4.39B+18.7% | $3.7B+48.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $1.11B+123% | $498M-25.0% | ||
| -$677M+12.3% | -$772M+2.6% | -$792.8M+2.1% | -$809.9M-2.9% | -$787.2M-60.3% | ||
| —— | —— | —— | —— | —— | ||
| -$7.06B-219% | -$2.21B— | —— | —— | —— | ||
| —— | —— | $10.3M-95.0% | $205.5M+259% | -$129.5M+56.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | $7B+20.9% | $5.79B+26.5% | $4.58B+36.0% | $3.37B+56.2% | ||
| —— | —— | —— | $2.86B+2.2% | $2.8B+4.2% | ||
| —— | $6.61B+14.2% | $5.79B+16.5% | $4.97B+19.7% | $4.15B+24.6% | ||
| $1.92B-33.9% | $2.91B+13.2% | $2.57B-45.8% | $4.74B0.0% | $4.74B+44.6% | ||
| $1.72B+160% | $661M+20.2% | $549.7M— | —— | —— | ||
| $141M+14,200% | -$1M-100% | $734M+123% | $329.8M+271% | $88.8M-64.2% | ||
| $1.46B-51.6% | $3.01B+6.1% | $2.84B-42.5% | $4.94B-1.4% | $5.01B+49.6% | ||
| $745M+15.5% | $645M-3.7% | $669.9M-15.7% | $794.8M+5.0% | $756.9M+11.8% | ||
| $8.66B+10.4% | $7.84B+15.5% | $6.79B+12.2% | $6.05B+8.5% | $5.58B+10.4% | ||
| -$677M+12.3% | -$772M+2.6% | -$792.8M+2.1% | -$809.9M-2.9% | -$787.2M-60.3% | ||
| —— | —— | —— | —— | —— | ||
| $11.82B+31.8% | $8.97B-3.2% | $9.27B+89.8% | $4.88B+30.7% | $3.74B-0.6% | ||
| $11.82B+31.8% | $8.97B-3.2% | $9.27B+89.8% | $4.88B+30.7% | $3.74B-0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Eli Lilly generate?
- Eli Lilly (LLY) generated $20.5B in operating cash flow over the trailing twelve months.
- What is Eli Lilly's free cash flow?
- After $8.7B of capital expenditures, Eli Lilly's free cash flow was $11.8B over the trailing twelve months, up 216.4% year over year.
- Where does Eli Lilly's cash flow data come from?
- Every line is extracted from Eli Lilly's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
